These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
245 related items for PubMed ID: 29570279
1. Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections: Promises and Perils. Siguier M, Molina JM. ACS Infect Dis; 2018 May 11; 4(5):660-663. PubMed ID: 29570279 [Abstract] [Full Text] [Related]
2. Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections. Luetkemeyer AF, Donnell D, Dombrowski JC, Cohen S, Grabow C, Brown CE, Malinski C, Perkins R, Nasser M, Lopez C, Vittinghoff E, Buchbinder SP, Scott H, Charlebois ED, Havlir DV, Soge OO, Celum C, DoxyPEP Study Team. N Engl J Med; 2023 Apr 06; 388(14):1296-1306. PubMed ID: 37018493 [Abstract] [Full Text] [Related]
3. Doxycycline prophylaxis for the prevention of sexually transmitted infections: A systematic review and meta-analysis of randomized controlled trials. Szondy I, Meznerics FA, Lőrincz K, Kemény LV, Walter A, Mohammed AA, Hegyi P, Kiss N, Bánvölgyi A. Int J Infect Dis; 2024 Oct 06; 147():107186. PubMed ID: 39122208 [Abstract] [Full Text] [Related]
4. Doxycycline postexposure prophylaxis for prevention of sexually transmitted infections. Cannon CA, Celum CL. Top Antivir Med; 2023 Dec 05; 31(5):566-575. PubMed ID: 38198668 [Abstract] [Full Text] [Related]
6. Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention. Oware K, Adiema L, Rono B, Violette LR, McClelland RS, Donnell D, Scoville CW, Odoyo J, Baeten JM, Bukusi E, Stewart J. BMC Womens Health; 2023 Jun 03; 23(1):296. PubMed ID: 37270546 [Abstract] [Full Text] [Related]
7. Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design. Molina JM, Bercot B, Assoumou L, Rubenstein E, Algarte-Genin M, Pialoux G, Katlama C, Surgers L, Bébéar C, Dupin N, Ouattara M, Slama L, Pavie J, Duvivier C, Loze B, Goldwirt L, Gibowski S, Ollivier M, Ghosn J, Costagliola D, ANRS 174 DOXYVAC Study Group. Lancet Infect Dis; 2024 Oct 03; 24(10):1093-1104. PubMed ID: 38797183 [Abstract] [Full Text] [Related]
8. [Do not overuse doxycycline as prophylaxis for uncomplicated sexually transmitted infections]. Filén F, Eriksen J, Missailidis C. Lakartidningen; 2024 Aug 02; 121():. PubMed ID: 39101261 [Abstract] [Full Text] [Related]
10. Position statement of the German STI Society on the prophylactic use of doxycycline to prevent STIs (Doxy-PEP, Doxy-PrEP). Werner RN, Schmidt AJ, Potthoff A, Spornraft-Ragaller P, Brockmeyer NH, German STI Society (DSTIG). J Dtsch Dermatol Ges; 2024 Mar 02; 22(3):466-478. PubMed ID: 38123738 [Abstract] [Full Text] [Related]
11. Doxycycline Prophylaxis to Prevent Sexually Transmitted Infections in Women. Stewart J, Oware K, Donnell D, Violette LR, Odoyo J, Soge OO, Scoville CW, Omollo V, Mogaka FO, Sesay FA, McClelland RS, Spinelli M, Gandhi M, Bukusi EA, Baeten JM, dPEP Kenya Study Team. N Engl J Med; 2023 Dec 21; 389(25):2331-2340. PubMed ID: 38118022 [Abstract] [Full Text] [Related]
12. Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex: a randomized, controlled pilot study. Bolan RK, Beymer MR, Weiss RE, Flynn RP, Leibowitz AA, Klausner JD. Sex Transm Dis; 2015 Feb 21; 42(2):98-103. PubMed ID: 25585069 [Abstract] [Full Text] [Related]
16. CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024. Bachmann LH, Barbee LA, Chan P, Reno H, Workowski KA, Hoover K, Mermin J, Mena L. MMWR Recomm Rep; 2024 Jun 06; 73(2):1-8. PubMed ID: 38833414 [Abstract] [Full Text] [Related]